NCT02963675View on ClinicalTrials.gov

Incidence of Second Primary Malignancies in Prostate Cancer Patients With Bone Metastases - an Observational Retrospective Cohort Study in Sweden

CompletedOBSERVATIONAL
Enrollment

15,953

Participants

Timeline

Start Date

November 15, 2016

Primary Completion Date

March 31, 2017

Study Completion Date

March 31, 2017

Conditions
Prostatic Neoplasms
Interventions
OTHER

external unexposed reference group

Trial Locations (1)

Unknown

Multiple Locations

Sponsors

Lead Sponsor

Bayer
All Listed Sponsors
lead

Bayer

INDUSTRY

NCT02963675 - Incidence of Second Primary Malignancies in Prostate Cancer Patients With Bone Metastases - an Observational Retrospective Cohort Study in Sweden | Biotech Hunter | Biotech Hunter